Concepedia

Author

Jeffrey Johnson

Cedars-Sinai Medical CenterORCID

Also Known As

Cindy Hsu, Donna Niedzwiecki, F. Thurston Drake, J Johnson, J. -E. JOHNSON, J. E. JOHNSON, J. Johnson, Jeff Johnson, Jeffery Johnson, Jeffrey E. Johnson

64

Publications

899

Citations

14

H-Index

53

Concepts

All Affiliations

Cedars-Sinai Medical CenterAllozyne (United States)
JJ

About

Jeffrey Johnson is an author at Cedars-Sinai Medical Center specializing in medicine, pathology, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

301

2

Natural Sciences

2

2

158

3

Allergy

1

1

21

4

Biochemistry

1

1

137

5

Biology

1

1

21

Jeffrey Johnson

×

13

Publications

541

Citations

11

H-Index

YearCitations

FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer

Bingchen Han, Ying Qu, Yanli Jin,

Cell Reports

2015

148

Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry

Michael Pete VanBrunt, Kurt Shanebeck, Zachary Caldwell,

Bioconjugate Chemistry

2015

137

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort

Jeffrey Johnson, Michael Choi, Farnaz Dadmanesh,

Oncotarget

2016

44

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance

Yi Yu-Rice, Yanli Jin, Bangwoo Han,

Oncogene

2016

41

Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors

Michael Marotta, Taku Onodera, Jeffrey Johnson,

Scientific Reports

2017

40

The role of pre‐operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary?

Nicholas Manguso, Alexandra Gangi, Jeffrey Johnson,

Journal of Surgical Oncology

2017

29

Screening protocol for Torulopsis (Candida) glabrata

G. Land, J Burke, C Shelby,

Journal of Clinical Microbiology

1996

21

Phase 2 Study of the g209-2M Melanoma Peptide Vaccine and Low-Dose Interleukin-2 in Advanced Melanoma

John D. Roberts, Donna Niedzwiecki, William E. Carson,

Journal of Immunotherapy

2005

21

AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model

Karin Stenderup, Cecilia Rosada, Kurt Shanebeck,

Protein Engineering Design and Selection

2015

16

Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors

Nicholas Manguso, Jeffrey Johnson, Attiya Harit,

The American Surgeon

2017

12

Page 1